تقرير
Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes
| العنوان: | Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes |
|---|---|
| المؤلفون: | Stargardt, Tom, Gonder-Frederick, Linda, Krobot, Karl J, Alexander, Charles M |
| بيانات النشر: | BioMed Central Ltd. |
| سنة النشر: | 2009 |
| المجموعة: | BioMed Central |
| الوصف: | Background To explore the concept of the Minimum Clinically Important Difference (MID) of the Worry Scale of the Hypoglycaemia Fear Survey (HFS-II) and to quantify the clinical importance of different types of patient-reported hypoglycaemia. Methods An observational study was conducted in Germany with 392 patients with type 2 diabetes mellitus treated with combinations of oral anti-hyperglycaemic agents. Patients completed the HFS-II, the Treatment Satisfaction Questionnaire for Medication (TSQM), and reported on severity of hypoglycaemia. Distribution- and anchor-based methods were used to determine MID. In turn, MID was used to determine if hypoglycaemia with or without need for assistance was clinically meaningful compared to having had no hypoglycaemia. Results 112 patients (28.6%) reported hypoglycaemic episodes, with 15 patients (3.8%) reporting episodes that required assistance from others. Distribution- and anchor-based methods resulted in MID between 2.0 and 5.8 and 3.6 and 3.9 for the HFS-II, respectively. Patients who reported hypoglycaemia with (21.6) and without (12.1) need for assistance scored higher on the HFS-II (range 0 to 72) than patients who did not report hypoglycaemia (6.0). Conclusion We provide MID for HFS-II. Our findings indicate that the differences between having reported no hypoglycaemia, hypoglycaemia without need for assistance, and hypoglycaemia with need for assistance appear to be clinically important in patients with type 2 diabetes mellitus treated with oral anti-hyperglycaemic agents. |
| نوع الوثيقة: | report |
| اللغة: | English |
| العلاقة: | http://www.hqlo.com/content/7/1/91Test |
| الإتاحة: | http://www.hqlo.com/content/7/1/91Test |
| حقوق: | Copyright 2009 Stargardt et al; licensee BioMed Central Ltd. |
| رقم الانضمام: | edsbas.6C7F7616 |
| قاعدة البيانات: | BASE |
| ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.6C7F7616 825 3 Report report 824.994262695313 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.6C7F7616&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => http://www.hqlo.com/content/7/1/91# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Stargardt%2C+Tom%22">Stargardt, Tom</searchLink><br /><searchLink fieldCode="AR" term="%22Gonder-Frederick%2C+Linda%22">Gonder-Frederick, Linda</searchLink><br /><searchLink fieldCode="AR" term="%22Krobot%2C+Karl+J%22">Krobot, Karl J</searchLink><br /><searchLink fieldCode="AR" term="%22Alexander%2C+Charles+M%22">Alexander, Charles M</searchLink> ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => BioMed Central Ltd. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2009 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => BioMed Central ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background To explore the concept of the Minimum Clinically Important Difference (MID) of the Worry Scale of the Hypoglycaemia Fear Survey (HFS-II) and to quantify the clinical importance of different types of patient-reported hypoglycaemia. Methods An observational study was conducted in Germany with 392 patients with type 2 diabetes mellitus treated with combinations of oral anti-hyperglycaemic agents. Patients completed the HFS-II, the Treatment Satisfaction Questionnaire for Medication (TSQM), and reported on severity of hypoglycaemia. Distribution- and anchor-based methods were used to determine MID. In turn, MID was used to determine if hypoglycaemia with or without need for assistance was clinically meaningful compared to having had no hypoglycaemia. Results 112 patients (28.6%) reported hypoglycaemic episodes, with 15 patients (3.8%) reporting episodes that required assistance from others. Distribution- and anchor-based methods resulted in MID between 2.0 and 5.8 and 3.6 and 3.9 for the HFS-II, respectively. Patients who reported hypoglycaemia with (21.6) and without (12.1) need for assistance scored higher on the HFS-II (range 0 to 72) than patients who did not report hypoglycaemia (6.0). Conclusion We provide MID for HFS-II. Our findings indicate that the differences between having reported no hypoglycaemia, hypoglycaemia without need for assistance, and hypoglycaemia with need for assistance appear to be clinically important in patients with type 2 diabetes mellitus treated with oral anti-hyperglycaemic agents. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => report ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => http://www.hqlo.com/content/7/1/91 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => http://www.hqlo.com/content/7/1/91 ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => Copyright 2009 Stargardt et al; licensee BioMed Central Ltd. ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.6C7F7616 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Stargardt, Tom
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Gonder-Frederick, Linda
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Krobot, Karl J
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Alexander, Charles M
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2009
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsbas.oa
)
)
)
)
)
)
)
|
| IllustrationInfo |